We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UNP:NYSEUnion Pacific Corporation Analysis

Data as of 2026-05-28 - not real-time

$279.39

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Union Pacific (UNP) is trading at $279.39, essentially at its 52‑week high and just below the technical resistance of $279.68, while comfortably above the 20‑day SMA ($267.68) and the 50‑day SMA ($255.88), signaling a strong bullish trend. Momentum indicators are supportive – the RSI sits at 67, the MACD line is above its signal, and volume is increasing – but the stock is approaching overbought territory and may face short‑term pressure near the resistance level. Fundamentally, UNP trades at a forward PE of 20.4 versus an industry average of 30.1, suggesting relative undervaluation, yet the DCF‑derived fair value of $51.2 and a price‑to‑book of 9.0 point to significant overvaluation on an absolute basis. The company delivers a 2.04% dividend yield with a 45% payout ratio, backed by solid operating cash flow ($9.5 B) and free cash flow ($4.0 B), though its debt‑to‑equity ratio of 162% raises balance‑sheet concerns. The pending merger with Norfolk Southern adds a major catalyst, offering potential scale synergies but also heightened regulatory risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price at technical resistance with high RSI
  • Increasing volume but elevated 30‑day volatility
  • Upcoming dividend ex‑date supports short‑term demand

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Potential merger synergies with Norfolk Southern
  • Strong cash generation and sustainable dividend
  • Relative PE advantage versus industry peers

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Durable railroad business model with stable earnings
  • High debt load requires careful balance‑sheet monitoring
  • Dividend reliability and modest growth outlook

Key Metrics & Analysis

Financial Health

Revenue Growth3.20%
Profit Margin29.20%
P/E Ratio22.3
ROE40.69%
ROA9.14%
Debt/Equity162.25
P/B Ratio9.0
Op. Cash Flow$9.5B
Free Cash Flow$4.0B
Industry P/E30.1

Technical Analysis

TrendBullish
RSI67.1
Support$261.04
Resistance$279.68
MA 20$267.68
MA 50$255.88
MA 200$238.66
MACDBullish
VolumeIncreasing
Fear & Greed Index92.34

Valuation

Fair Value$51.21
Target Price$291.05
Upside/Downside4.17%
GradeOvervalued
TypeBlend
Dividend Yield2.04%

Risk Assessment

Beta0.48
Volatility30.99%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.